Today, Benzinga's options scanner identified 8 options transactions for Illumina. This is an unusual occurrence. The ...

We offer Illumina microarray processing and expertise accessible to both internal and external researchers. If you would like to discuss your assays or enquire about costs and scheduling, please ...

Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications. Market Capitalization: Indicating a ...

Late last year, Illumina discontinued its microRNA microarrays, the better to focus on sequencing. Cost should no longer keep researchers away from deep sequencing, says Shawn Baker, market ...

SHANGHAI, March 4 (Reuters) - China announced a ban on Tuesday on imports of genetic sequencers from U.S. medical equipment maker Illumina (ILMN.O), opens new tab ...

China’s Ministry of Commerce said it would ban Illumina, a San Diego company, from importing its gene-mapping products in China. Illumina is the world’s leading producer of gene-sequencing ...

Manufacturer and investor interest may also protect the array market. As Illumina and ABI both have microarray products, it doesn't make sense for them to cannibalize their existing markets with ...

Wall Street analysts forecast that Illumina (ILMN) will report quarterly ... It is projected by analysts that the 'Revenue- Microarrays- Instruments' will reach $4.20 million.